Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Mexico Medical Cannabis Market: By Product: Buds, Oils, Tinctures; By Application: Chronic Pain, Mental Disorders, Cancer, Others; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand; Competitive Landscape; Industry Events and Developments
Mexico Medical Cannabis Market Outlook
The Mexico medical cannabis market size was estimated at nearly USD 0.08 billion in 2020. The market is expected to grow at a CAGR of 46.4% over the forecast period of 2022-2027 to reach USD 0.68 billion by 2026
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing acceptance of medical cannabis to treat chronic circumstances like cancer, neurological diseases, and chronic pain is the main factor driving for the industry for medical cannabis in Mexico.
Properties and Applications
Cannabis or marijuana is a psychoactive drug, which is derived from the cannabis plant, which is further used for medical purposes. The Mexico medical cannabis market can be divided based on segments like products and applications.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be divided based on its products as buds, oils, and tinctures.
The industry can be broadly categorised based on its application into:
- Chronic Pain
- Mental Disorders
- Cancer
- Others
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
Due to the significant population and patient pool, medical cannabis is anticipated to emerge as one of the most profitable enterprises to enter Mexico in the coming years. Different research studies have demonstrated the potential benefits of cannabis in cancer treatment, thus increasing its demand for cancer therapy. The growing burden of disease and the increasing cannabis use for medical purposes are anticipated to drive the demand for the product over the forecast period. The oil segment is anticipated to emerge as the fastest growing segment by 2026.
Competitive Landscape
The report presents a detailed analysis of the following key players in the Mexico medical cannabis market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Sartorius de México S.A. de C.V. (Sartorius AG)
- Aurora Cannabis
- GW Pharmaceuticals, plc.
- Canopy Growth Corporation.
- HempMeds
- CV Sciences, Inc.
- ENDOCA
- Isodiol International, Inc.
- CBD Life
- PharmaCielo
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application |
| Breakup by Product | Buds, Oils, Tinctures |
| Breakup by Application | Chronic Pain, Mental Disorders, Cancer, Others |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Sartorius de México S.A. de C.V. (Sartorius AG), Aurora Cannabis, GW Pharmaceuticals, plc., Canopy Growth Corporation., HempMeds, CV Sciences, Inc., ENDOCA, Isodiol International, Inc., CBD Life, PharmaCielo, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Mexico
7 Industry Opportunities and Challenges
8 Mexico Medical Cannabis Market Analysis
8.1 Key Industry Highlights
8.2 Mexico Medical Cannabis Historical Market (2017-2021)
8.3 Mexico Medical Cannabis Market Forecast (2022-2027)
8.4 Mexico Medical Cannabis Market by Product
8.4.1 Buds
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Oils
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Tinctures
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.5 Mexico Medical Cannabis Market by Application
8.5.1 Chronic Pain
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Mental Disorders
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Cancer
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Others
9 Market Dynamics
9.1 SWOT Analysis
9.1.1 Strengths
9.1.2 Weaknesses
9.1.3 Opportunities
9.1.4 Threats
9.2 Porter’s Five Forces Analysis
9.2.1 Supplier’s Power
9.2.2 Buyer’s Power
9.2.3 Threat of New Entrants
9.2.4 Degree of Rivalry
9.2.5 Threat of Substitutes
9.3 EMR’s Key Indicators for Demand
9.4 EMR’s Key Indicators for Price
10 Competitive Landscape
10.1 Market Structure
10.2 Company Profiles
10.2.1 Sartorius de México S.A. de C.V. (Sartorius AG)
10.2.1.1 Company Overview
10.2.1.2 Product Portfolio
10.2.1.3 Demographic Reach and Achievements
10.2.1.4 Certifications
10.2.2 Aurora Cannabis Inc.
10.2.2.1 Company Overview
10.2.2.2 Product Portfolio
10.2.2.3 Demographic Reach and Achievements
10.2.2.4 Certifications
10.2.3 GW Pharmaceuticals plc
10.2.3.1 Company Overview
10.2.3.2 Product Portfolio
10.2.3.3 Demographic Reach and Achievements
10.2.3.4 Certifications
10.2.4 Canopy Growth Corporation.
10.2.4.1 Company Overview
10.2.4.2 Product Portfolio
10.2.4.3 Demographic Reach and Achievements
10.2.4.4 Certifications
10.2.5 HempMeds
10.2.5.1 Company Overview
10.2.5.2 Product Portfolio
10.2.5.3 Demographic Reach and Achievements
10.2.5.4 Certifications
10.2.6 CV Sciences, Inc.
10.2.6.1 Company Overview
10.2.6.2 Product Portfolio
10.2.6.3 Demographic Reach and Achievements
10.2.6.4 Certifications
10.2.7 Endoca B.V.
10.2.7.1 Company Overview
10.2.7.2 Product Portfolio
10.2.7.3 Demographic Reach and Achievements
10.2.7.4 Certifications
10.2.8 Isodiol International, Inc.
10.2.8.1 Company Overview
10.2.8.2 Product Portfolio
10.2.8.3 Demographic Reach and Achievements
10.2.8.4 Certifications
10.2.9 CBD Life
10.2.9.1 Company Overview
10.2.9.2 Product Portfolio
10.2.9.3 Demographic Reach and Achievements
10.2.9.4 Certifications
10.2.10 PharmaCielo
10.2.10.1 Company Overview
10.2.10.2 Product Portfolio
10.2.10.3 Demographic Reach and Achievements
10.2.10.4 Certifications
10.2.11 Others
11 Industry Events and Developments
List of Figures and Tables
1. Mexico Medical Cannabis Market: Key Industry Highlights, 2017 and 2027
2. Mexico Medical Cannabis Historical Market: Breakup by Product (USD Million), 2017-2021
3. Mexico Medical Cannabis Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Mexico Medical Cannabis Historical Market: Breakup by Application (USD Million), 2017-2021
5. Mexico Medical Cannabis Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Mexico Medical Cannabis Market Structure
Key Questions Answered in the Report
The Mexico medical cannabis market reached a value of USD 0.08 billion in 2020.
The market is expected to grow at a CAGR of about 46.4% in the forecast period of 2022-2027.
The industry is expected to expand in the forecast period to reach USD 0.68 billion by 2026.
The major drivers of the market, such as the rising disposable incomes and the growing acceptance of medical cannabis to treat chronic circumstances like cancer, neurological diseases, and chronic pain in the industry, are expected to aid the industry growth.
The emerging oils segment is expected to define the market growth in the coming years.
The major product segments in the market are buds, oils, and tinctures.
Chronic pain, mental disorders, and cancer, among others, are the leading application segments for the market.
The major players in the market are Sartorius de México S.A. de C.V. (Sartorius AG), Aurora Cannabis, GW Pharmaceuticals, plc., Canopy Growth Corporation., HempMeds, CV Sciences, Inc., ENDOCA, Isodiol International, Inc., CBD Life, and PharmaCielo, among others.
Analyst Review
The Mexico medical cannabis market attained a value of USD 0.08 billion in 2020, driven by the growing acceptance of medical cannabis to treat chronic circumstances like cancer, neurological diseases, and chronic pain. It is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 46.4% to reach a value of almost USD 0.68 billion by 2026. The industry is projected to be driven by the emerging oils segment in the forecast period of 2022-2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of product, the market is divided into buds, oils, and tinctures. On the basis of application, the industry is divided into chronic pain, mental disorders, and cancer, among others. The key players in the above industry include Sartorius de México S.A. de C.V. (Sartorius AG), Aurora Cannabis, GW Pharmaceuticals, plc., Canopy Growth Corporation., HempMeds, CV Sciences, Inc., ENDOCA, Isodiol International, Inc., CBD Life, PharmaCielo, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global vaccine market attained a value of nearly USD 57.55 billion in 2021, driven by the rising prevalence of chronic illnesses worldwide. Aided by the growing investments in the pharmaceutical i...
The global immunotherapy drugs market attained a value of nearly USD 179.6 billion in 2021, driven by the rising prevalence of cancer and other chronic illnesses worldwide. Aided by the growing invest...
The global anisole market attained a value of about USD 94.09 million in 2021, driven by the rising application of anisole in the pharmaceutical industry. Aided by the thriving e-commerce industry, th...
The global antiviral drugs market attained a value of more than USD 62.7 billion in 2021, driven by the rising cases of viral infections among the geriatrics, and rising healthcare expenditure. The ma...
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing...
NEWSLETTER